12:00 AM
 | 
Jun 05, 2000
 |  BC Week In Review  |  Company News  |  Deals

Genelabs deal

GNLB began submission of an NDA to the FDA for its GL701 dehydroepiandrosterone (DHEA) hormone as first...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >